HealthInvest Partners AB Q1 2022 holdings

$62.8 Million is the total value of HealthInvest Partners AB's 12 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 84.6% .

 Value Shares↓ Weighting
MCK SellMCKESSON CORP$9,184
+8.7%
30,000
-11.8%
14.62%
+22.8%
IRWD SellIRONWOOD PHARMACEUTICALS INC$8,932
+4.9%
710,000
-2.7%
14.22%
+18.6%
BMY SellBRISTOL-MYERS SQUIBB CO$5,988
-4.0%
82,000
-18.0%
9.53%
+8.5%
BIIB NewBIOGEN INC$5,89728,000
+100.0%
9.39%
HRMY SellHARMONY BIOSCIENCES HLDGS IN$5,838
-29.8%
120,000
-38.5%
9.30%
-20.7%
GILD NewGILEAD SCIENCES INC$5,82698,000
+100.0%
9.28%
CI NewCIGNA CORP NEW$5,75124,000
+100.0%
9.16%
CAH SellCARDINAL HEALTH INC$5,670
-11.9%
100,000
-20.0%
9.03%
-0.5%
UTMD BuyUTAH MED PRODS INC$5,032
+25.8%
56,000
+40.0%
8.01%
+42.1%
LJPC SellLA JOLLA PHARMACEUTICAL CO$3,019
-21.8%
707,000
-14.8%
4.81%
-11.6%
KMPH NewKEMPHARM INC$1,283255,000
+100.0%
2.04%
OPNT NewOPIANT PHARMACEUTICALS INC$38618,000
+100.0%
0.62%
RIGL ExitRIGEL PHARMACEUTICALS INC$0-1,090,000
-100.0%
-4.07%
ICPT ExitINTERCEPT PHARMACEUTICALS IN$0-183,000
-100.0%
-4.20%
ZGNX ExitZOGENIX INC$0-195,000
-100.0%
-4.47%
LCI ExitLANNET INC$0-2,000,000
-100.0%
-4.57%
ABC ExitAMERISOURCEBERGEN CORP$0-48,000
-100.0%
-8.99%
ABBV ExitABBVIE INC$0-48,000
-100.0%
-9.16%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Angelika Andersson — CFO

Compare quarterly holdings

Export HealthInvest Partners AB's holdings

EDGAR filings